AVITROL PLUS PRAZIQUANTEL BIRD WORMER TABLETS

Šalis: Australija

kalba: anglų

Šaltinis: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Veiklioji medžiaga:

LEVAMISOLE AS LEVAMISOLE HYDROCHLORIDE; PRAZIQUANTEL

Prieinama:

MAVLAB PTY. LTD.

INN (Tarptautinis Pavadinimas):

levamisole as HCl(16.96mg/Tb)+praziquantel(4mg/Tb)

Vaisto forma:

ORAL TABLET

Sudėtis:

LEVAMISOLE AS LEVAMISOLE HYDROCHLORIDE ANTHELMINTIC Active 16.96 mg/Tb; PRAZIQUANTEL ANTHELMINTIC Active 4.0 mg/Tb

Vienetai pakuotėje:

100 Tabs

Klasė:

VM - Veterinary Medicine

Farmakoterapinė grupė:

BIRDS | AVIARY BIRD | BREEDERS | BROILERS | BUDGERIGARS | CANARIES | CHICKENS | CHOOKS | DOMESTIC BIRDS | DUCKS | EMU | FINCHES

Gydymo sritis:

PARASITICIDES

Terapinės indikacijos:

CAECAL WORM - HETERALSIS SPP. | GAPEWORM - SYNGAMUS SPP. | GIZZARD WORM | ROUNDWORM - ASCARIDIA SPP. | TAPEWORM - RAILLIETINA SPP. | THREADWORM - CAPILLARIA SPP. | HAIR WORM | HETERAKIS SPP.

Produkto santrauka:

Poison schedule: 5; Withholding period: WHP: NOT APPLICABLE; Host/pest details: BIRDS: [CAECAL WORM - HETERALSIS SPP., GAPEWORM - SYNGAMUS SPP., GIZZARD WORM, ROUNDWORM - ASCARIDIA SPP., TAPEWORM - RAILLIETINA SPP., THREADWORM - CAPILLARIA SPP.]; Poison schedule: 5; Withholding period: ; Host/pest details: BIRDS: [CAECAL WORM - HETERALSIS SPP., GAPEWORM - SYNGAMUS SPP., GIZZARD WORM, ROUNDWORM - ASCARIDIA SPP., TAPEWORM - RAILLIETINA SPP., THREADWORM - CAPILLARIA SPP.]; For the treatment of threadworm, caecal worm, roundworm, gape worm, gizzard worm and tapeworm in caged birds over 250 g bodyweight.Not to be used in food producing species. Treatment during breeding or racing (pigeon) seasons is not recommended. Avoid handling birds for 10 mins after treatment.

Autorizacija statusas:

Registered

Leidimo data:

2023-07-01

Pakuotės lapelis

DRAFT
LABEL
• FRONT PANEL
CAUTION
KEEP OUT OF THE REACH OF CWLDREN
FOR
ANIMAL
TREATMENT
ONLY
Avitrol Plus Praziquantel
Bird WonnerTabJets
Active
Constituents:
Each tablet
contains:
20mg
LEV
AMISOLE
HYDROCHLORIDE
equivalent to
16.96mg
LEVAMISOLE base.
4tng
PRAZIQUANTEL.
For
the
treatment
of
Threadworm
(Coptllarla
spp),
Caecalworm
_(Heterakis_
spp).
Roundworm
_(Ascaridia_ spp),
Gape worm
_(Syngamus_
spp),
Gizzard
worm
_(Acuaria_
spp)
and
Tapeworm
_(Raillietina_
spp)
in
Caged
Birdsover 250g
bodyweight.
-
.
100
TABLETS
MAVLAB
Pty
Ltd 33Rowland St, Slacks Creek, QLD
N.R.A.
APPROVED
LABEL
Date'
~
.
..•
::.
:~.
.'
' . '
.,...
.
..
'~
.•
"c'
"",'., ",
...
:'\".
....
'~.,
.
...
~.,
...
".~
.,
....
-..
~~
.
..
.".'
DRAFTLABEL-
SECOND
PANEL
Directions
for
use:
Not
to
be
used
IN
FOOD
produdnl
species.
Administer orally by placing in the
throat
of
the
bird, at
a
rate
of
40mglkg
bobyweight
(BW)
Levamisole hydrochloride
and
8mglkg
BW
Praziquantel, or
~
tablet for birds of
2So-S00g
BW, I tablet
for
birds
S

Perskaitykite visą dokumentą

Prekės savybės

MAVLAB PTY LTD
Date of Issue:
November 2007
MATERIAL SAFETY DATA SHEET
AVITROL PLUS TABLETS
Page 1 of 5
MSDS version:
3
Date of Revision:
November, 2007
Update of section:
All sections
SECTION 1 IDENTIFICATION OF THE MATERIAL AND SUPPLIER
Product (material) name:
Avitrol Plus Praziquantel Bird Wormer Tablets
Other names:
Avitrol Plus Tablets; Manufacturer’s code: P1180
Recommended use:
For the control of worm infestations in caged birds.
Supplier Details:
Mavlab Pty Ltd ACN 068 507 148
31 – 33 Rowland Street
SLACKS CREEK QLD 4127
Contact Person:
Dr Paul Ross
Emergency Telephone:
[phone]
Facsimile:
[phone]
SECTION 2 HAZARDS IDENTIFICATION
This product is not dangerous goods under the Australian Dangerous
Goods Code but is classified as hazardous
hazardous
according
to
the
classification
criteria
of
NOHSC:1008(2004),
Approved
Criteria
For
Classifying
Hazardous Substances and the National Code of Practice for the
Preparation of Material Safety Data Sheets 2
nd
Edition [NOHSC:2011(2003)]:
Health Effects
Although this product contains levamisole hydrochloride at a
concentration above that which is considered to be
hazardous according to the classification criteria of NOHSC
1008(2004), this material is present in tablet form and
the quantities of tablets are limited. It is considered therefore that
the product does not pose a significant hazard.
Nevertheless the following information should be noted:
Swallowed:
Nausea, vomiting, headache, dizziness, abdominal pain may be noted
following
very large doses of product. Considered an unlikely route of entry in
commercial/industrial environments.
Eye:
May cause slight transient eye irritation. Corneal injury is unlikely.
Skin:
Prolonged contact is essentially non-irritating to skin. Repeated
exposure may
cause slight flaking, tenderness and softening of the skin. A single
prolonged
exposure is not likely to result in the material being absorbed
through the skin in
harmful amounts.
Inhaled:
Considered to be an unlikely route of exposure, since the material i